Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
1.19
0.01 (0.85%)
At close: Jun 02, 2025, 3:59 PM
1.19
0.20%
After-hours: Jun 02, 2025, 07:34 PM EDT

Prime Medicine Revenue Breakdown

Period Ending Dec 31, 2024
Reportable Segment Revenue 2.98M
Reportable Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Dec 31, 2019
Selling, General, and Administrative Revenue 13.28M 12.3M 14.1M 12.6M 11.16M 13.08M 10.49M 10.66M 9.15M 9.63M 6.61M 7.37M 6.22M 7.19M 3.03M 2.32M 1.39M 1.25M 1.25M
Selling, General, and Administrative Revenue Growth +7.99% -12.77% +11.90% +12.93% -14.72% +24.70% -1.56% +16.44% -4.90% +45.66% -10.28% +18.39% -13.44% +137.43% +30.42% +67.10% +10.94% 0.00% n/a
Research and Development Revenue 40.56M 34.1M 40.34M 43.07M 37.77M 41.46M 40.97M 34.6M 30.88M 29.06M 25.05M 18.94M 13.68M 52.89M 7.4M 5.7M 4.57M 920K 920K
Research and Development Revenue Growth +18.94% -15.46% -6.34% +14.02% -8.89% +1.20% +18.41% +12.04% +6.26% +16.03% +32.24% +38.48% -74.14% +614.72% +29.94% +24.73% +396.30% 0.00% n/a